|
Volumn 24, Issue 14, 2014, Pages 3194-3198
|
Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity
|
Author keywords
DOPAL; Dopamine; Fibrils; NMR; Thioflavin T; Synuclein
|
Indexed keywords
ALPHA SYNUCLEIN;
AMYLOID;
ANTIARRHYTHMIC AGENT;
CATECHOLAMINE;
PARAQUAT;
POLYPHENOL;
QUERCETIN;
RESVERATROL;
THIOFLAVINE;
THIAZOLE DERIVATIVE;
3,4 DIHYDROXYPHENYLACETALDEHYDE;
CONGO RED;
DOPAMINE;
DOPAMINE DERIVATIVE;
FLAVONOID;
FLUORESCENT DYE;
UNCLASSIFIED DRUG;
AQUEOUS SOLUTION;
ARTICLE;
ARTIFACT;
DRUG MONITORING;
FLUORESCENCE;
HEART FIBRILLATION;
IN VITRO STUDY;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
OXIDATION;
PARKINSON DISEASE;
CHEMISTRY;
DRUG EFFECTS;
HUMAN;
METABOLISM;
PROTEIN TERTIARY STRUCTURE;
STRUCTURE ACTIVITY RELATION;
ANTIFIBRILLOGENIC ACTIVITY;
CARBOXY TERMINAL SEQUENCE;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG SCREENING;
HETERONUCLEAR SINGLE QUANTUM COHERENCE;
NUCLEAR MAGNETIC RESONANCE;
PROTEIN AGGREGATION;
PROTEIN FOLDING;
PROTEIN INTERACTION;
ALPHA-SYNUCLEIN;
AMYLOID;
ARTIFACTS;
HUMANS;
PROTEIN STRUCTURE, TERTIARY;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIAZOLES;
|
EID: 84902537346
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2014.04.072 Document Type: Article |
Times cited : (48)
|
References (28)
|